Starting a Cannabis Business in Denmark

Licensing
Required
Foreign Ownership
Allowed
Timeline
18-30 months from application to operational status
Business Types
3
Medical Cannabis CultivationPharmaceutical ProcessingCBD Products

Market Overview

Denmark has established itself as one of Europe's most significant medical cannabis production hubs, attracting hundreds of millions of euros in investment from international cannabis companies. The country's strong pharmaceutical industry infrastructure, skilled workforce, and progressive regulatory environment have made it attractive for large-scale GACP/GMP cannabis cultivation and processing operations. Major facilities operate in regions like Jutland, producing medical cannabis for both the domestic pilot program and export markets. The domestic medical cannabis pilot program, launched in 2018 and subsequently extended, allows Danish patients to access cannabis products through pharmacies with a physician's prescription. Separately, the Freetown Christiania in Copenhagen has long operated as a de facto cannabis market on Pusher Street, though this exists outside the legal framework and has been subject to police action. For entrepreneurs, Denmark offers opportunities in licensed cultivation, pharmaceutical processing, and export, but the capital requirements are substantial and the market favors well-funded, pharmaceutical-grade operations.

Capital Requirements

High; GACP/GMP cultivation and processing facilities require EUR 5-20 million in investment

Application Process

1

Establish a Danish legal entity (ApS or A/S) and register with the Danish Business Authority (Erhvervsstyrelsen).

2

Apply to the Danish Medicines Agency (Laegemiddelstyrelsen) for a cannabis cultivation and/or processing license under the Danish medical cannabis pilot program framework.

3

Submit detailed facility plans, security specifications, quality management documentation, and proof of financial capacity and pharmaceutical expertise.

4

Construct or retrofit facilities meeting GACP (cultivation) and GMP (processing) requirements, subject to Danish Medicines Agency inspection and approval.

5

Receive licensing approval and begin operations under the ongoing pilot program, complying with all reporting, testing, and traceability requirements.

Estimated timeline: 18-30 months from application to operational status

Key Regulations

  • •Denmark's medical cannabis pilot program launched in 2018 and has been extended, allowing patients access to domestically produced and imported cannabis products.
  • •The Danish Medicines Agency regulates all cannabis cultivation, processing, and distribution under the pilot framework.
  • •Christiania's Pusher Street has operated outside the legal framework as a de facto open cannabis market, though subject to periodic police enforcement.
  • •Denmark hosts some of Europe's largest cannabis cultivation facilities, with companies like Aurora and others investing heavily.

Opportunities

+

World-class pharmaceutical infrastructure supporting high-quality cannabis production.

+

Established export market position with Danish-produced cannabis reaching Germany and other European markets.

+

Strong government support for the medical cannabis pilot program and pharmaceutical innovation.

+

Skilled labor force with deep expertise in pharmaceutical manufacturing and quality assurance.

Challenges

!

Very high capital requirements for GACP/GMP facilities (EUR 5-20 million or more).

!

Small domestic patient market limiting revenue from in-country sales.

!

Several early cannabis cultivation companies have faced financial difficulties despite large investments.

!

Stringent regulatory requirements and the pharmaceutical-grade operational standard create high ongoing compliance costs.

Frequently Asked Questions

What happened to Christiania's cannabis market?

Christiania's Pusher Street has been an open cannabis market for decades but operates outside Denmark's legal framework. It has been subject to periodic police raids and enforcement actions. The Christiania community has itself taken steps to distance from the drug trade. It is not a legal model for cannabis business.

Is Denmark good for cannabis cultivation?

Denmark is excellent for pharmaceutical-grade indoor cannabis cultivation, offering strong pharmaceutical infrastructure, skilled labor, and a supportive regulatory environment. However, the climate is not suitable for outdoor cultivation, and capital requirements are high (EUR 5-20 million for a licensed facility).

How does the Danish medical cannabis pilot work?

The pilot program allows doctors to prescribe cannabis products to patients who have not responded to conventional treatments. Products are dispensed through pharmacies and include both domestically produced and imported items. The program has been extended multiple times and is expected to become permanent.

Related Country Guides

Starting a Cannabis Business in Germany

Guide to starting a cannabis business in Germany. Learn about cannabis social clubs, medical distribution licenses, cultivation permits, and the CanG regulatory framework.

Starting a Cannabis Business in Netherlands

How to start a cannabis coffeeshop or CBD business in the Netherlands. Licensing requirements, the back-door problem, Wietexperiment, and AHOJGI compliance guide.

Starting a Cannabis Business in Czech Republic

Starting a cannabis business in the Czech Republic. Medical cannabis distribution, SUKL licensing, CBD retail regulations, and opportunities in Central Europe's most tolerant market.

Explore More

All European Markets|Europe Overview|Legalization Tracker|Industry Analysis

Disclaimer: This information is for educational purposes only and does not constitute legal, financial, or business advice. Cannabis regulations in Denmark are subject to change. Consult with qualified legal and financial professionals familiar with Denmark's regulatory framework before starting any cannabis-related business. Cannabismarketcap does not guarantee the accuracy or completeness of any information presented.